Yuki Fujioka
Akita, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Ravulizumab administration for relapse prevention in atypical hemolytic uremic syndrome with a CFH variant: A case report.
Journal: Internal medicine (Tokyo, Japan)
Published: June 10, 2026
Treatment-Free Remission and Immune Profiling after Frontline Second-Generation TKI Therapy in CML.
Journal: Blood advances
Published: May 05, 2026
Long-term treatment-free remission in CML after early dasatinib discontinuation due to interstitial pneumonitis.
Journal: International journal of hematology
Published: April 10, 2026
Ponatinib inhibits LCK and PI3K signaling and promotes CD8+ T stem cell memory cell development.
Journal: Nature communications
Published: March 24, 2025
Seasonal occurrence of nonepisodic angioedema with eosinophilia: A case series of 12 patients.
Journal: Asia Pacific allergy
Published: December 26, 2024
Stopping bosutinib reverses bosutinib-induced elevation of serum creatinine in patients with chronic myeloid leukemia.
Journal: International journal of hematology
Published: December 14, 2024
Bosutinib for Successful Treatment-Free Remission in Chronic Myeloid Leukemia.
Journal: Cancer medicine
Published: December 05, 2024
Inhibition of EETosis with an anti-citrullinated histone antibody: a novel therapeutic approach for eosinophilic inflammatory disorders.
Journal: Frontiers in immunology
Published: November 29, 2024
Ponatinib Improved the Prognosis of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Japanese Single-Center Cohort Study.
Journal: Cureus
Published: December 12, 2023
The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axis.
Journal: Blood
Published: October 03, 2022
Last Updated: 09/26/2026